"SILVAMP TB LAM" Rapid Urine Tuberculosis Test Predicts Mortality in Patients Hospitalized With Human Immunodeficiency Virus in South Africa. (9th January 2020)

• Record Type: Journal Article
• Authors: Sossen, Bianca; Broger, Tobias; Kerkhoff, Andrew D; Schutz, Charlotte; Trollip, Andre; Moreau, Emmanuel; Schumacher, Samuel G; Burton, Rosie; Ward, Amy; Wilkinson, Robert J; Barr, David A; Nicol, Mark P; Denkinger, Claudia M; Meintjes, Graeme
• Is Part Of: Clinical infectious diseases. Volume 71:Number 8(2020)
• Page Start: 1973
• Page End: 1976
• Publication Date: 2020-01-09
• Subjects: Tuberculosis -- HIV -- lipoarabinomannan -- point-of-care -- mortality; Communicable diseases -- Periodicals; 616.905
• DOI: 10.1093/cid/ciaa024
• Languages: English
• ISSNs: 1058-4838

Abstract

Abstract: Reducing diagnostic delay is key toward decreasing tuberculosis-associated deaths in people living with human immunodeficiency virus. In tuberculosis patients with retrospective urine testing, the point-of-care Fujifilm SILVAMP TB LAM (FujiLAM) could have rapidly diagnosed tuberculosis in up to 89% who died. In FujiLAM negative patients, the probability of 12-week survival was 86–97%.